Parliamentary panel recommends evaluation of vaccines, more research for booster dose

Published On 2021-12-07 11:54 GMT   |   Update On 2021-12-07 11:54 GMT

As with the emergence of a new Omicron variant of SARS-CoV-2, speculations are being made about the possibility of a new wave of the pandemic, the Parliamentary Standing Committee on Health, has recently recommended that evaluation of the efficacy of COVID vaccines is necessary and more research on the part on the part of the Government is required for examining the need for booster doses...

Login or Register to read the full article

As with the emergence of a new Omicron variant of SARS-CoV-2, speculations are being made about the possibility of a new wave of the pandemic, the Parliamentary Standing Committee on Health, has recently recommended that evaluation of the efficacy of COVID vaccines is necessary and more research on the part on the part of the Government is required for examining the need for booster doses for containing the new strain of the virus.

While presenting its report before the Parliament on Friday, the panel referred to the growing concerns regarding the new strain developing immunoescape mechanism and opined the need for critically addressing the issue.

"With the incidence of highly mutated Omicron (B.1.1.529) strain of Covid virus, the committee strongly believes that the efficacy of the vaccines must be evaluated. The concerns with regards to the new strain developing immunoescape mechanism need to be critically addressed," the Parliamentary Committee was quoted stating in its report by PTI.

For more details, check out the full story on the link below: 

Parliamentary Panel Addresses Concerns On Omicron Variant, Recommends Evaluation Of Vaccines, More Research For Booster Dose

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News